Deskripsi
Stool frequency normalization rates are compared between the synbiotic-treated and placebo groups across the 8-week trial period.
Figure 12
ChartSource Paper
The Effectiveness of Synbiotic Preparation Containing Lactobacillus and Bifidobacterium Probiotic Strains and Short Chain Fructooligosaccharides in Patients with Diarrhea Predominant …Cite This Figure
![Figure 12: Stool frequency normalization rates are compared between the synbiotic-treated and placebo groups across the 8-week trial period.]() > Source: Barbara Skrzydło-Radomańska et al. "The Effectiveness of Synbiotic Preparation Containing Lactobacillus and Bifidoba." *Nutrients*, 2020. PMID: [32635661](https://pubmed.ncbi.nlm.nih.gov/32635661/)
<figure> <img src="" alt="Stool frequency normalization rates are compared between the synbiotic-treated and placebo groups across the 8-week trial period." /> <figcaption>Figure 12. Stool frequency normalization rates are compared between the synbiotic-treated and placebo groups across the 8-week trial period.<br> Source: Barbara Skrzydło-Radomańska et al. "The Effectiveness of Synbiotic Preparation Containing Lactobacillus and Bifidoba." <em>Nutrients</em>, 2020. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/32635661/">32635661</a></figcaption> </figure>
Bukti Terkait
B
Bifidobacterium longum untuk Irritable Bowel Syndrome (IBS)
B
Peringkat B · 4 studi
Galactooligosaccharides (GOS) untuk Irritable Bowel Syndrome (IBS)
B
Peringkat B · 3 studi
Lactobacillus acidophilus untuk Irritable Bowel Syndrome (IBS)
D
Peringkat B · 3 studi
Fructooligosaccharides (FOS) untuk Irritable Bowel Syndrome (IBS)
Peringkat D · 2 studi